Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)

18.580
-0.560
(-2.93%)
At close: April 25 at 4:08:21 PM GMT+8
Currency in CNY All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
527,754
527,754
334,090
177,912
27,631
Cost of Revenue
142,766
142,766
81,421
46,031
11,344
Gross Profit
384,988
384,988
252,669
131,881
16,287
Operating Expense
529,422
529,422
474,855
350,215
114,070
Operating Income
-144,434
-144,434
-222,186
-218,334
-97,783
Net Non Operating Interest Income Expense
77,789
77,789
94,843
12,787
-306
Pretax Income
-78,734
-78,734
-113,555
-199,689
-100,468
Net Income Common Stockholders
-78,734
-78,734
-113,555
-199,689
-100,468
Diluted NI Available to Com Stockholders
-78,734
-78,734
-113,555
-199,689
-100,468
Basic EPS
-0.24
--
-0.34
-0.68
-0.31
Diluted EPS
-0.24
--
-0.34
-0.68
-0.31
Basic Average Shares
328,711
--
330,388
294,595
323,401.001
Diluted Average Shares
328,711
--
330,388
294,595
323,401.001
Total Operating Income as Reported
-156,523
-156,523
-208,398
-212,476
-100,162
Total Expenses
672,188
672,188
556,276
396,246
125,414
Net Income from Continuing & Discontinued Operation
-78,734
-78,734
-113,555
-199,689
-100,468
Normalized Income
-69,614
-69,614
-109,018
-213,634
-102,120
Interest Income
79,040
79,040
95,565
13,094
360
Interest Expense
1,251
1,251
722
307
666
Net Interest Income
77,789
77,789
94,843
12,787
-306
EBIT
-77,483
-77,483
-112,833
-199,382
-99,802
EBITDA
-41,603
-41,603
-86,565
-186,000
-90,164
Reconciled Cost of Revenue
142,766
142,766
81,421
46,031
11,344
Reconciled Depreciation
35,880
35,880
26,268
13,382
9,638
Net Income from Continuing Operation Net Minority Interest
-78,734
-78,734
-113,555
-199,689
-100,468
Total Unusual Items Excluding Goodwill
-9,120
-9,120
-4,537
13,945
1,652
Total Unusual Items
-9,120
-9,120
-4,537
13,945
1,652
Normalized EBITDA
-32,483
-32,483
-82,028
-199,945
-91,816
12/31/2020 - 7/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers